🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Excited to share our latest study "Induction of NK cell reactivity against acute myeloid leukemia by Fc-optimized CD276 (B7-H3) antibody" in Blood Cancer Journal. Congrats to Sylwia A. Stefańczyk Melly M and all contributors! 🎉 #AML #Leukemia #immunotherapy #ADCC nature.com/articles/s4140…

🏆 April Lab #TourDeForce Champs! 🎉 -Boris Klimovich 🟡🎽 pioneering anticancer breakthroughs -Polina Kaidun races in 🟢🎽 for innovation -Nisha Prakash ⚪️🔴🎽conquers experimental frontiers -Emma Nill 🦅🎽tackles cell culture hurdles with Eddie the Eagle spirit!

💫 Exciting news! Our B7H3xCD3 #bispecific #antibody CC-3 shows promise in fighting bone & soft tissue sarcomas. Congrats to Samuel Holzmayer & team! Melly M Visualizing and Targeting Cancer Stress #immunotherapy ➡️frontiersin.org/journals/immun…

🏆 May Lab #TourDeForce Heroes! 🎉 🟡🎽Tatjana Schreiber leads with precision in mentoring 🟢🎽Emma Nill excels in #bispecific constructs cloning ⚪️🔴🎽Nisha Prakash masters experimental optimization of #Tcells Polina Kaidun bravely tackles hurdles with the Eddie the 🦅🎽 spirit!

Happy and proud to be part of the ENDO-RELIEF project in collaboration with Melly M from Translational Immunology supported by the @BMBF_Bund aiming to better understand the development of #endometriosis. gesundheitsforschung-bmbf.de/de/endometrios…

An optimized IgG-based B7-H3xCD3 bispecific antibody for treatment of gastrointestinal cancers. A study by Translational Immunology & others in Molecular Therapy #ASCO24 hubs.li/Q02yvLpR0

We are starting a phase-I #clinicaltrial for our #peptide #vaccine against acute myeloid leukemia (AML). We are looking for #AML #patients after first-line therapy and aim to avoid relapse due to minimal residual disease. For more information, check out: medizin.uni-tuebingen.de/de/aml-impfsto…

Our Teams (Peptide-based Immunotherapy and Translational Immunology) are looking forward to this upcoming #event fostering bench to bedside translation. ekfs.de/aktuelles/vera…

The Lab #TourDeForce June champs: - Polina Kaidun 🟡🎽 for novel #Tcell constructs - Britta Statz 🟢🎽for screening of #bispecific costimulators - Martina Lutz ⚪️🔴🎽 for target restricted checkpoint inhibitors - Nisha Prakash Eddie the 🦅🎽 for perseverance despite no new data

#Farewell to our #postdoc, Polina Kaidun. Her work on novel class of #Tcell engaging constructs was invaluable. Best wishes on her new #journey! 👩🏻‍🔬✨ #ThankYou

✨Thrilled to share our new paper on Novel B7-H3 #CD276 #antibody in #AML published in Cancers MDPI! Congrats to our #PhD student Sylwia A. Stefańczyk, @Lsfm3DNSCsClara and the team led by Melanie Märklin Melly M! MDPI Visualizing and Targeting Cancer Stress mdpi.com/2857480

Now online - check out this video from Karin Strube where Juliane Walz introduces our new phase I #ClinicalTrial for an #immunopeptidomics-based #peptide #vaccine for #patients with #AML. youtube.com/watch?v=tFuY4X…

Glad to announce our ACE2-M fusion protein, effective against SARS-CoV-2 escape variants, won the #Science2Start award! Congrats Dr. Latifa Zekri and team! #BioRegioSTERN bioregio-stern.de/de/presse/ausg…

Another great white party in the heart of #Tübingen together with Translational Immunology! 🥂 We officially announce the ennoblement of the Lady and Lord of the Glen!

🎉Celebrating our annual White Party together with Peptide-based Immunotherapy.🎉 Proud to announce the ennoblement of Lady Juliane and Lord Helmut of the Glen! #Tuebingen

Announcing August Lab #TourDeForce Champs: - Martina Lutz: 🎽🟡Bispecific checkpoint inhibitors - Jonas Mauermann: 🎽🟢 Lightning-fast cytotoxicity assays - Nisha Prakash: 🎽⚪️🔴 Tetramer staining success - Boris Klimovich: 🎽🦅 Superagonistic T cell engagers

Our wakeboarding trip couldn’t happen this year, but the team still had a great time. Thanks to Jonas and Melly for organizing! #teamspirit #bbq

PhD position in Immunology of #Endometriosis at Uni Hospital Tübingen! Join the ENDO-RELIEF project (65%, 3 years, with extension option). Apply by 25.11.2024. More info: jobs.medizin.uni-tuebingen.de/Job/5289 #PhDPosition #Immunology #Endometriosis #ResearchJobs #jobalert #hiring